South Korea's Celltrion gets UK approval for trials of COVID-19 antibody drug

This post was originally published on this site

https://i-invdn-com.akamaized.net/trkd-images/LYNXNPEG6T050_L.jpg

The company will enrol participants for a clinical study in the UK after approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), Celltrion said in a statement.

South Korean regulators on July 17 approved an early stage clinical trial for the drug, making it the country’s first such antibody drug to be tested on humans.